Apixaban is also used to treat DVT or pulmonary embolism (PE), and to lower your risk of having a repeat DVT or PE.Apixaban may also be used for purposes not listed in this medication guide.Apixaban side effectsGet emergency medical help if you have signs of an allergic reaction: hives;...
Background Enoxaparin, a thromboprophylactic drug that is widely used for preventing deep venous thrombosis (DVT) and surgical wound complications after total knee replacement surgery, can only be administered subcutaneously. Apixaban, a novel factor Xa inhibitor that could be comparable to enoxaparin, ...
Apixaban is also used to treat DVT or pulmonary embolism (PE), and to lower your risk of having a repeat DVT or PE. Apixaban may also be used for purposes not listed in this medication guide. Certifications Company Profile ComWin International Co.,Ltd was founded in 1992. Changzhou Co...
ELIQUIS is indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery. Treatment Of Deep Vein Thrombosis ELIQUIS is indicated for the treatment of DVT. Treatment Of Pulmonary Embolism ELIQU...
ELIQUIS is indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery. Treatment Of Deep Vein Thrombosis ELIQUIS is indicated for the treatment of DVT. ...
It is also indicated for the treatment of PE and for the treatment of DVT. Finally, apixaban; is indicated it patients to reduce the risk of recurrent DVT and PE following initial therapy. HUMAN EXPOSURE AND TOXICITY: Premature discontinuation of any oral anticoagulant, including apixaban;, in ...
To prevent the formation of adeep vein thrombosis(also known as a DVT or blood clot in the veins) orpulmonary embolism(blood clot in the lungs) after hip or knee replacement surgery To treat blood clots that can form in your veins or lungs and prevent them from happening again ...
Assess patient for symptoms of stroke, DVT, PE, bleeding, or peripheral vascular disease periodically during therapy.Toxicity and Overdose: Antidote is andexanet alfa. Effects persist for at least 24 hrs after last dose. Oral activated charcoal decreases apixaban absorption, lowering plasma concentra...
Apixaban was found to be associated with lower risk of symptomatic DVT and bleeding compared to enoxaparin when used for thromboprophylaxis in patients ... MR Aryal,A Pandit,S Ghimire,... - 《Journal of Community Hospital Internal Medicine Perspectives》 被引量: 55发表: 2015年 Key features of...
Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study. Summary. Background: Apixaban, an oral potent reversible direct inhibitor of activated factor X, has shown promise in the prevention of venous thromboembol...